Medicinal cannabis
November 21, 2023
The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia. With this emerging field comes the need for comprehensive
The prescribing and supply of medicinal cannabis is a rapidly expanding area of practice in Australia. With this emerging field comes the need for comprehensive
Off-label prescribing occurs when a medication is used for a purpose that is not approved by the Australian Therapeutic Goods Administration (TGA). It may involve
The PDL Professional Officers often manage calls, incident reports and occasional regulatory complaints following a pharmacist’s decision to decline supply of a medication. Recently, the
PDL has observed a recent trend in pharmacists being duped into supplying medication, usually S8 or S4s on fraudulent prescriptions by con artists who are
PDL employs four pharmacist Professional Officers who are available 24/7 for PDL members. From the thousands of calls and emails received every year by the
The PDL Professional Officers often see incident reports or regulatory notifications involving high risk medications such as S8 items and benzodiazepines. These incidents can involve
The recent experiences of pharmacists dealing with the challenges of the COVID-19 pandemic will help to inform practice into the future. One aspect of practice